Skip to main content
. 2019 Oct 23;47(12):6016–6026. doi: 10.1177/0300060519862469

Table 1.

Patient demographics.

Sex
 Male 97 (55.7%)
 Female 77 (44.3%)
Age (years)
 Median (IQR) 61 (55-69)
Histopathological subtypes
 NSCLC, A 103 (59.2%)
 NSCLC, SCC 59 (33.7%)
 NSCLC, Mixed Adeno/Squamous 3 (1.7%)
 NSCLC undifferentiated 9 (5.2%)
Median overall survival 38.4 months

IQR, interquartile range; NSCLC, non-small cell lung cancer; SCC, squamous cell carcinoma.